טוען...
p47(phox) deficiency improves cognitive impairment and attenuates tau hyperphosphorylation in mouse models of AD
BACKGROUND: Alzheimer’s disease (AD) is characterized by progressive memory loss and cognitive impairment. The aggregation of amyloid β (Aβ) and hyperphosphorylated tau protein are two major pathological features of AD. Nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase, NOX) has bee...
שמור ב:
| הוצא לאור ב: | Alzheimers Res Ther |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7659091/ https://ncbi.nlm.nih.gov/pubmed/33183342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-020-00714-2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|